Cargando…
Sclerotherapy with 3% polidocanol foam for third- and fourth-degree hemorrhoids as “bridge treatment” during the COVID-19 pandemic in Italy
PURPOSE: In Italy, colorectal surgery has been strongly affected with the vast majority (90%) of operations treating benign diseases, with an estimated overall 12-week cancellation rate of 72%. Little is known on how to best manage patients with benign diseases and the consequences this interruption...
Autores principales: | Lisi, Giorgio, Campanelli, M., Grande, S., Milito, G., Grande, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811334/ https://www.ncbi.nlm.nih.gov/pubmed/33452908 http://dx.doi.org/10.1007/s00384-021-03848-3 |
Ejemplares similares
-
Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes
por: Pata, Francesco, et al.
Publicado: (2021) -
Sclerotherapy for III- and IV-degree hemorrhoids: Results of a prospective study
por: Lisi, Giorgio, et al.
Publicado: (2022) -
Polidocanol foam sclerotherapy in the treatment of hemorrhoidal disease in patients with bleeding disorders: a multicenter, prospective, cohort study
por: Salgueiro, P., et al.
Publicado: (2022) -
Sclerotherapy using polidocanol foam for a giant splenic cyst
por: Funakoshi, Hiraku, et al.
Publicado: (2020) -
Foam Polidocanol Sclerotherapy for Low-Flow Vascular Malformations of Tongue
por: Mukul, Sailesh Kumar, et al.
Publicado: (2019)